Page last updated: 2024-08-24

amprenavir and Dyslipidemia

amprenavir has been researched along with Dyslipidemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ai, N; Helsley, RN; Park, SH; Sui, Y; Welsh, WJ; Zhou, C	1

Other Studies

1 other study(ies) available for amprenavir and Dyslipidemia

Article	Year
Pregnane X receptor mediates dyslipidemia induced by the HIV protease inhibitor amprenavir in mice. Molecular pharmacology, 2013, Volume: 83, Issue:6 Topics: Animals; Binding Sites; Carbamates; Cell Line; Dyslipidemias; Furans; Gene Expression; HIV Protease Inhibitors; Humans; Lipids; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Docking Simulation; Pregnane X Receptor; Receptors, Steroid; Sulfonamides	2013

Article

Year

Pregnane X receptor mediates dyslipidemia induced by the HIV protease inhibitor amprenavir in mice.

Molecular pharmacology, 2013, Volume: 83, Issue:6

Topics: Animals; Binding Sites; Carbamates; Cell Line; Dyslipidemias; Furans; Gene Expression; HIV Protease Inhibitors; Humans; Lipids; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Docking Simulation; Pregnane X Receptor; Receptors, Steroid; Sulfonamides

2013